IGRT 45 Gy in 5 fractions of 9 Gy

RADIATION2 trials

Sponsors

Fundacao Champalimaud, Albert Einstein College of Medicine

Conditions

PROSTATE CANCERProstate Cancer

Phase 1

A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

Active, not recruitingNCT04147806

Albert Einstein College of MedicineProstate Cancer

Start: 2016-08-01End: 2026-07-01Updated: 2026-04-03

Unknown Phase

Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate Cancer

CompletedNCT02570919

Fundacao ChampalimaudPROSTATE CANCER

Start: 2015-09-01End: 2017-12-31Updated: 2019-07-23

Related Papers

Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer

JAMA Oncology2021-03-1167 citations

Single-dose radiotherapy (SDRT) in the management of intermediate risk prostate cancer: Early results from a phase II randomized trial.

Journal of Clinical Oncology2018-02-207 citations